1492 Capital Management LLC Seelos Therapeutics, Inc. Transaction History

1492 Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.66 - $259.46 $1,160 - $456,130	-1,758 Reduced 1.76%	98,061 $66,000
Q1 2022 May 12, 2022	SELL	$0.84 - $1.71 $7,112 - $14,478	-8,467 Reduced 7.82%	99,819 $84,000
Q3 2021 Nov 12, 2021	BUY	$1.69 - $2.89 $550 - $942	326 Added 0.3%	108,286 $261,000
Q2 2021 Aug 13, 2021	SELL	$2.64 - $6.32 $3,960 - $9,480	-1,500 Reduced 1.37%	107,960 $285,000
Q1 2021 May 12, 2021	SELL	$1.35 - $4.99 $54,729 - $202,294	-40,540 Reduced 27.03%	109,460 $546,000
Q1 2020 May 12, 2020	BUY	$0.47 - $1.56 $70,500 - $234,000	150,000 New	150,000 $74,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $40.5M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on 1492 Capital Management LLC with notifications on news.